Cargando…

Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer

BACKGROUND: Bladder cancer (BLCA) is a common malignant tumor of the urinary tract, which is the sixth most common cancer among men. Numerous studies suggested that pyroptosis and long noncoding RNAs (lncRNAs) played an essential role in the development of cancers. However, the role of pyroptosis-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hongcheng, Wu, Jiajin, Liang, Linghui, Wang, Xinwei, Cai, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828980/
https://www.ncbi.nlm.nih.gov/pubmed/35154117
http://dx.doi.org/10.3389/fimmu.2022.803355
_version_ 1784647964608692224
author Lu, Hongcheng
Wu, Jiajin
Liang, Linghui
Wang, Xinwei
Cai, Hongzhou
author_facet Lu, Hongcheng
Wu, Jiajin
Liang, Linghui
Wang, Xinwei
Cai, Hongzhou
author_sort Lu, Hongcheng
collection PubMed
description BACKGROUND: Bladder cancer (BLCA) is a common malignant tumor of the urinary tract, which is the sixth most common cancer among men. Numerous studies suggested that pyroptosis and long noncoding RNAs (lncRNAs) played an essential role in the development of cancers. However, the role of pyroptosis-related lncRNAs in BLCA and their prognostic value are still unclear. METHODS: In this study, we constructed a signature model through least absolute shrinkage and selection operator (LASSO) Cox regression analysis and Cox univariate analysis based on The Cancer Genome Atlas (TCGA) database. The expression of 12 pyroptosis-related lncRNAs was also confirmed by qRT-PCR in BLCA cell lines. TIMER, XCELL, QUANTISEQ, MCPCOUNTER, EPIC, and CIBERSORT R script were applied to quantify the relative proportions of infiltrating immune cells. Correlation coefficients were computed by Spearman analyses. The Kaplan–Meier method, Cox regression model, and log-rank tests were used to evaluate the prognostic value. The R package of pRRophetic was used to predict IC50 of common chemotherapeutic agents. RESULTS: A total of 12 pyroptosis-related lncRNAs with great prognosis value were identified. The expression was investigated by qRT-PCR in four BLCA cell lines. Then, 126 cases were identified as high-risk group, and 277 cases were identified as low-risk group based on the cutoff point. Patients in the low-risk group showed a significant survival advantage. Furthermore, we found that clinical features were significantly related to the risk score. As well, based on the C-index values, a nomogram was constructed. The gene set enrichment analysis (GSEA) results showed that mitogen-activated protein kinase (MAPK) signaling, transforming growth factor (TGF)-β signaling, and WNT signaling were with important significance in the high-risk group. Moreover, we found that riskscore was positively correlated with M0 macrophages and M2 macrophages. CONCLUSIONS: In conclusion, our study indicated that pyroptosis is closely connected to BLCA. The riskscore generated from the expression of 12 pyroptosis-related lncRNAs was evaluated by various clinical features including survival status, tumor microenvironment, clinicopathological characteristic, and chemotherapy. It may offer a significant basis for future studies.
format Online
Article
Text
id pubmed-8828980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88289802022-02-11 Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer Lu, Hongcheng Wu, Jiajin Liang, Linghui Wang, Xinwei Cai, Hongzhou Front Immunol Immunology BACKGROUND: Bladder cancer (BLCA) is a common malignant tumor of the urinary tract, which is the sixth most common cancer among men. Numerous studies suggested that pyroptosis and long noncoding RNAs (lncRNAs) played an essential role in the development of cancers. However, the role of pyroptosis-related lncRNAs in BLCA and their prognostic value are still unclear. METHODS: In this study, we constructed a signature model through least absolute shrinkage and selection operator (LASSO) Cox regression analysis and Cox univariate analysis based on The Cancer Genome Atlas (TCGA) database. The expression of 12 pyroptosis-related lncRNAs was also confirmed by qRT-PCR in BLCA cell lines. TIMER, XCELL, QUANTISEQ, MCPCOUNTER, EPIC, and CIBERSORT R script were applied to quantify the relative proportions of infiltrating immune cells. Correlation coefficients were computed by Spearman analyses. The Kaplan–Meier method, Cox regression model, and log-rank tests were used to evaluate the prognostic value. The R package of pRRophetic was used to predict IC50 of common chemotherapeutic agents. RESULTS: A total of 12 pyroptosis-related lncRNAs with great prognosis value were identified. The expression was investigated by qRT-PCR in four BLCA cell lines. Then, 126 cases were identified as high-risk group, and 277 cases were identified as low-risk group based on the cutoff point. Patients in the low-risk group showed a significant survival advantage. Furthermore, we found that clinical features were significantly related to the risk score. As well, based on the C-index values, a nomogram was constructed. The gene set enrichment analysis (GSEA) results showed that mitogen-activated protein kinase (MAPK) signaling, transforming growth factor (TGF)-β signaling, and WNT signaling were with important significance in the high-risk group. Moreover, we found that riskscore was positively correlated with M0 macrophages and M2 macrophages. CONCLUSIONS: In conclusion, our study indicated that pyroptosis is closely connected to BLCA. The riskscore generated from the expression of 12 pyroptosis-related lncRNAs was evaluated by various clinical features including survival status, tumor microenvironment, clinicopathological characteristic, and chemotherapy. It may offer a significant basis for future studies. Frontiers Media S.A. 2022-01-27 /pmc/articles/PMC8828980/ /pubmed/35154117 http://dx.doi.org/10.3389/fimmu.2022.803355 Text en Copyright © 2022 Lu, Wu, Liang, Wang and Cai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lu, Hongcheng
Wu, Jiajin
Liang, Linghui
Wang, Xinwei
Cai, Hongzhou
Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
title Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
title_full Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
title_fullStr Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
title_full_unstemmed Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
title_short Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
title_sort identifying a novel defined pyroptosis-associated long noncoding rna signature contributes to predicting prognosis and tumor microenvironment of bladder cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828980/
https://www.ncbi.nlm.nih.gov/pubmed/35154117
http://dx.doi.org/10.3389/fimmu.2022.803355
work_keys_str_mv AT luhongcheng identifyinganoveldefinedpyroptosisassociatedlongnoncodingrnasignaturecontributestopredictingprognosisandtumormicroenvironmentofbladdercancer
AT wujiajin identifyinganoveldefinedpyroptosisassociatedlongnoncodingrnasignaturecontributestopredictingprognosisandtumormicroenvironmentofbladdercancer
AT lianglinghui identifyinganoveldefinedpyroptosisassociatedlongnoncodingrnasignaturecontributestopredictingprognosisandtumormicroenvironmentofbladdercancer
AT wangxinwei identifyinganoveldefinedpyroptosisassociatedlongnoncodingrnasignaturecontributestopredictingprognosisandtumormicroenvironmentofbladdercancer
AT caihongzhou identifyinganoveldefinedpyroptosisassociatedlongnoncodingrnasignaturecontributestopredictingprognosisandtumormicroenvironmentofbladdercancer